Company / Current Assets
LIXTE BIOTECHNOLOGY HOLDINGS, INC. Current Assets History
FY2011-FY2015 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$598.0K
FY2015
5-year range
$429.8K / $1.8M
FY2011-FY2015
Trend
+7.2%
vs FY2014
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $2M to $597,975 over the past 3 years.
Based on SEC 10-K filings.
$597,975 in FY2015 with a 3-year CAGR of -30.1%.
Declined from $2M to $597,975 over the past 3 years.
Current Assets over time
Growth rates
- 3-Year CAGR
- -30.1%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of -30.1%, indicating a declining trend.
- In FY2015, current assets increased 7.2% year-over-year.
Company context
Key Data Points
- Altman Z-Score -11.44 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2015 | $598.0K | +7.2% |
| FY2013 | $558.0K | -68.2% |
| FY2012 | $1.8M | +307.9% |
| FY2011 | $429.8K | - |
As of FY2015 · SEC 10-K · Updated Jun 24, 2026